checkAd
    Startseite > Aktien > Stoke Therapeutics > Nachrichten
    Stoke Therapeutics Aktie
    10,800
     
    EUR
    -2,70 %
    -0,300 EUR
    Letzter Kurs 08.05.24 Tradegate
    10,700
     
    EUR
    377 STK
    Geldkurs 11:59:00
    10,900
     
    EUR
    364 STK
    Briefkurs 11:59:00
    ISIN: US86150R1077 · WKN: A2PLTL · SYM: 0GT · USA

    Neueste Nachrichten

    Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates
    06.05.24 · Business Wire (engl.) · Stoke Therapeutics
    Stoke Therapeutics Appoints Thomas Leggett as Chief Financial Officer
    29.04.24 · Business Wire (engl.) · Stoke Therapeutics
    Stoke Therapeutics Appoints Jason Hoitt as Chief Commercial Officer
    17.04.24 · Business Wire (engl.) · Stoke Therapeutics
    Stoke Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
    04.04.24 · Business Wire (engl.) · Stoke Therapeutics
    Stoke Therapeutics Announces Pricing of Upsized $125 Million Public Offering
    28.03.24 · Business Wire (engl.) · Stoke Therapeutics
    Stoke Therapeutics Announces Proposed Public Offering
    26.03.24 · Business Wire (engl.) · Stoke Therapeutics
    Stoke Therapeutics Announces Landmark New Data That Support the Potential for STK-001 to be the First Disease-Modifying Medicine for the Treatment of Patients with Dravet Syndrome
    25.03.24 · Business Wire (engl.) · Stoke Therapeutics
    Stoke Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
    25.03.24 · Business Wire (engl.) · Stoke Therapeutics
    Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
    17.01.24 · Business Wire (engl.) · Stoke Therapeutics
    Stoke Therapeutics Highlights Strategic Priorities and Anticipated Milestones for 2024
    08.01.24 · Business Wire (engl.) · Stoke Therapeutics
    Stoke Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
    04.01.24 · Business Wire (engl.) · Stoke Therapeutics
    Stoke Therapeutics Presents Data From Multiple Studies of Children and Adolescents With Dravet Syndrome at the American Epilepsy Society (AES) 2023 Annual Meeting
    01.12.23 · Business Wire (engl.) · Stoke Therapeutics